Casa
o que significa a fórmula y=c+i+g+(x-m)

The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3

Por um escritor misterioso

Descrição
IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Frontiers Insights of Worsening Renal Function in Type 1
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Kidney and heart interactions during cardiorenal syndrome: a
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
The role of SGLT2 inhibitors in type 2 diabetes mellitus with
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Acute Cardiorenal Syndrome: Epidemiology, Pathophysiology
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
IJMS, Free Full-Text
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Type 4 cardiorenal syndrome Revista Portuguesa de Cardiologia
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Acute cardiorenal syndrome: Mechanisms and clinical implications
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Cardiovascular Alterations and Structural Changes in the Setting
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Cardiorenal syndrome: Pathophysiology as a key to the therapeutic
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Anemia of cardiorenal syndrome - Kidney International Supplements
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Edgar V. Lerma 🇵🇭 on X: 5 subtypes of #Cardiorenal syndrome
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Pathophysiology of the cardio-renal syndromes types 1–5: An
de por adulto (o preço varia de acordo com o tamanho do grupo)